Johnson & Johnson Innovation: Seoul Innovation QuickFire Challenge: Healthcare in the New Normal
The Seoul Innovation QuickFire Challenge for Healthcare in the New Normal seeks the best ideas aiming to address and enable potential healthcare solutions in the post-COVID era. Interests include health technologies, e-health platforms, rapid diagnostics for rare diseases, companion diagnostics for oncology, and smart systems for vaccine distribution and patient adherence.
Amount: Up to two innovators with the best ideas aiming to address and enable potential healthcare solutions in the post-COVID era will receive up to KRW150,000,000 (approximately US$125,000) in grant funding, residency at the Seoul Bio Hub, and mentorship and coaching from experts at the Johnson & Johnson Family of Companies.
Eligibility: Individuals, entrepreneurs, academics, biotech researchers, or an early-stage company that is less than 60 months old.
Deadline: August 31, 2020.
|Funder||Johnson & Johnson|
|Eligibility||For Profit Organization, Individual|
|Sector||COVID-19 Emergency Response, Health|